Status:
UNKNOWN
Effect of Butyrogenic Fibers in IBS Patients
Lead Sponsor:
University Hospital, Clermont-Ferrand
Collaborating Sponsors:
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
EA 3848 UdA
Conditions:
Irritable Bowel Syndrome
Eligibility:
FEMALE
18-60 years
Phase:
NA
Brief Summary
Despite there being no clearcut advantages, one of the most common recommendations in IBS management is to increase the amount of dietary fibres. In some IBS patients fibres have a deleterious effect ...
Detailed Description
Despite there being no clearcut advantages, one of the most common recommendations in IBS management is to increase the amount of dietary fibres. In some IBS patients fibres have a deleterious effect ...
Eligibility Criteria
Inclusion
- Female aged 18-60 years
- Normal volunteers and patients with IBS assessed by Rome II criteria
- Effective contraception
- Affiliated to National Health Service
- Having received oral and written information about the study
- Having provided her written informed consent
Exclusion
- Significant clinical or biological abnormality
- Organic gastrointestinal disease
- Subjects having lower than 15g/day or higher than 20g/day fibres intake
- Antibiotic treatment during the month preceding the pre inclusion day
- Antispasmodics, antidiarrheics, laxatives, and prokinetics during the week preceding the pre inclusion day and during all the study period.
- Digestive surgery tract except appendectomy and cholecystectomy
- Alcohol abuse
- Drug addiction
- Major psychiatric disorder
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2005
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00314886
Start Date
January 1 2005
End Date
July 1 2005
Last Update
January 19 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clermont-Ferrand University Hospital
Clermont-Ferrand, Auvergne, France, 63000